Resilient Cameco stock holds around $100 as uranium rally cools

Cameco stock is consolidating near $100 with recent declines in both its NYSE and TSX listings, while analysts maintain bullish long-term targets on the uranium producer.

Cameco Corp. (ISIN CA13321L1085) stock is trading close to $100 on the New York Stock Exchange as of August 29, 2026, after a sharp pullback in recent sessions that has cooled the earlier uranium trade but left the company’s long-term outlook and guidance intact. Per recent market data, Cameco’s NYSE-listed shares are quoted at $100.01 with a single-day decline of 5.9 percent on August 28, 2026, while the Toronto-listed CCO line closed at C$139.11 after a 5.58 percent drop in the same session.

Stock under pressure on both NYSE and TSX

Market data compiled for uranium-focused equities show Cameco’s dual listings retreating from recent highs, with the TSX quote at C$139.11 and the NYSE quote at $100.01 as of August 29, 2026, both reflecting declines of more than 5 percent in the latest completed trading session. A uranium sector overview highlights that the TSX line traded between C$138.48 and C$147.47 on the day, while the NYSE line moved between $99.53 and $106.44, underscoring the volatility that has followed the prior rally.

A separate performance snapshot focused on Cameco’s NYSE line shows the stock at $100.55 on August 29, 2026, effectively flat intraday, after the shares had already given up 5.9 percent at a close of $100.01 on August 28, 2026. A recent consolidation report notes that this level near $100 follows a period of pronounced volatility driven by changing sentiment in the uranium trade, where speculative interest has cooled and investors are reassessing the pace of future gains.

Analyst targets remain well above current price

While Cameco stock has eased back on both NYSE and TSX, consensus analyst targets remain significantly above current trading levels, suggesting that many coverage teams still expect upside tied to the company’s uranium and nuclear fuel exposure. An analyst-consensus overview reports that several research firms recently raised their price objectives on the TSX listing, with one target lifted to C$195, another to C$190, and others to C$175, framing Cameco as a buy-rated uranium producer despite the recent pullback.

On the NYSE line, consensus data indicate a price target of $145.68 and a rating described as a moderate buy, placing the $100.01 to $100.55 trading band roughly 31 percent below the average target. An institutional-investment update cites this target in the context of new portfolio allocations, implying that some long-term investors view the current consolidation phase as compatible with a still-attractive fundamental story. For retail investors, the number stands out: a roughly $45.67 gap between the latest consensus target and the prevailing $100 mark signals that professional coverage is not yet aligned with the recent price softness.

Valuation debate and recent drawdown

The recent drawdown has also intensified debate on Cameco’s valuation against cash flow and sales metrics. A valuation-focused note on the TSX listing argues that Cameco screens as overvalued based on discounted cash flow estimates and sales-based multiples, with both lenses pointing in the same direction. This view contrasts with the bullish price targets, underscoring how expectations for uranium demand and nuclear capacity additions are being weighed against current financial outputs.

Short-term price action has clearly been negative, with the TSX quote down 5.58 percent to C$139.11 and the NYSE quote down 5.9 percent to $100.01 at the August 28, 2026 close, according to sector-wide data and performance snapshots. A trading-session recap notes that Cameco’s slide left it underperforming the broader Canadian benchmark, reinforcing the sense that uranium-exposed equities are digesting earlier gains. For investors, the quantified comparison is stark: a single-session drop of more than 5 percent, yet a consensus target still pointing more than 30 percent higher than the latest NYSE close.

Operational and uranium-market backdrop

Beyond the price charts, Cameco’s role in the uranium supply chain remains central to the long-term narrative. A recent strategic analysis describes Cameco as a producer supplying uranium for electricity generation across the Americas, Europe, and Asia, reflecting its diversified geographic demand base. The same analysis discusses how plans around the Westinghouse stake and the broader uranium outlook intersect, suggesting that Cameco’s position as a major supplier supports long-term fundamentals even as short-term trading swings remain pronounced.

Sector data compiled across uranium names show that Cameco is one of the most actively traded Canadian energy stocks, with the TSX line appearing among the most active listings at a price of C$139.11 and a daily percentage change of -5.58 percent. A most-active list of Canadian stocks places CCO among the top traded names, reflecting meaningful liquidity and ongoing investor interest despite the recent cooling of speculative uranium flows.

Representative product: uranium for nuclear fuel

A representative product of Cameco’s business model is its uranium output used in nuclear fuel for power reactors. The company’s operations focus on mining and processing uranium, which is then converted and enriched as part of the nuclear fuel cycle and ultimately used by utilities to generate baseload electricity in multiple regions. Analysis of Cameco’s role in the uranium market emphasizes its ability to serve utilities across North America, Europe, and Asia, linking mine production to long-term supply contracts that underpin cash flow visibility and strategic relevance for the global push toward low-carbon power generation.

Cameco stock consolidation around the $100 level

As of August 29, 2026, Cameco’s NYSE-listed shares trade around $100.01 to $100.55, while the TSX-listed CCO shares stand at C$139.11 after recent declines, illustrating a consolidation phase that follows the prior uranium rally and leaves the stock trading well below consensus targets yet still above many historical benchmarks. For investors, the current picture is defined by that combination of double-digit single-session drawdowns, a price band concentrated near the $100 mark, and analyst targets pointing toward roughly $145.68 on the NYSE line, a spread that keeps Cameco stock firmly in the conversation among uranium and nuclear-energy plays.

Fact box

Company: Cameco Corp.

ISIN: CA13321L1085

Ticker: CCJ / CCO

Exchange: New York Stock Exchange / Toronto Stock Exchange

Price (as of August 29, 2026, 4:00 p.m. ET): $100.55 USD / C$139.11

Market cap: not stated in cited sources

Sector / Industry: Energy - Uranium and nuclear fuel

Index membership: S&P 500 (for NYSE line), S&P/TSX Composite Index